Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 119 | 2024 | 4470 | 8.660 |
Why?
|
Coronary Stenosis | 38 | 2024 | 794 | 7.380 |
Why?
|
Plaque, Atherosclerotic | 44 | 2024 | 1532 | 6.630 |
Why?
|
Coronary Artery Disease | 97 | 2024 | 6403 | 5.940 |
Why?
|
Coronary Vessels | 46 | 2024 | 3095 | 4.540 |
Why?
|
Acute Coronary Syndrome | 40 | 2024 | 2190 | 4.520 |
Why?
|
Chest Pain | 40 | 2024 | 1091 | 4.350 |
Why?
|
Tomography, X-Ray Computed | 84 | 2023 | 20556 | 2.530 |
Why?
|
Predictive Value of Tests | 69 | 2024 | 15251 | 2.140 |
Why?
|
Angina Pectoris | 8 | 2021 | 959 | 2.080 |
Why?
|
Troponin I | 8 | 2022 | 650 | 1.570 |
Why?
|
Societies, Medical | 14 | 2024 | 3900 | 1.280 |
Why?
|
Troponin | 8 | 2024 | 502 | 1.230 |
Why?
|
Fractional Flow Reserve, Myocardial | 4 | 2020 | 324 | 1.150 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 15 | 2024 | 1222 | 0.970 |
Why?
|
Exercise Test | 8 | 2020 | 2127 | 0.900 |
Why?
|
Cardiology | 10 | 2024 | 1656 | 0.890 |
Why?
|
Anniversaries and Special Events | 1 | 2024 | 95 | 0.880 |
Why?
|
Risk Assessment | 42 | 2024 | 23972 | 0.850 |
Why?
|
Heart Diseases | 9 | 2023 | 2778 | 0.810 |
Why?
|
Calcinosis | 13 | 2018 | 1469 | 0.750 |
Why?
|
Calcium | 13 | 2023 | 5717 | 0.730 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15498 | 0.710 |
Why?
|
Tomography, Spiral Computed | 8 | 2008 | 273 | 0.700 |
Why?
|
Prognosis | 37 | 2024 | 29600 | 0.690 |
Why?
|
Myocardial Infarction | 20 | 2023 | 11459 | 0.670 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2024 | 3244 | 0.660 |
Why?
|
Atherosclerosis | 7 | 2024 | 3400 | 0.620 |
Why?
|
Tomography, Optical Coherence | 11 | 2024 | 2916 | 0.610 |
Why?
|
Humans | 216 | 2024 | 760617 | 0.590 |
Why?
|
Risk Factors | 50 | 2024 | 74115 | 0.550 |
Why?
|
Severity of Illness Index | 26 | 2024 | 15828 | 0.530 |
Why?
|
Middle Aged | 116 | 2024 | 220584 | 0.520 |
Why?
|
Primary Prevention | 2 | 2024 | 1185 | 0.510 |
Why?
|
Radiographic Image Enhancement | 9 | 2014 | 876 | 0.510 |
Why?
|
Hemodynamics | 2 | 2024 | 4160 | 0.500 |
Why?
|
Emergency Service, Hospital | 23 | 2023 | 7871 | 0.490 |
Why?
|
Coronary Disease | 8 | 2017 | 5912 | 0.490 |
Why?
|
Constriction, Pathologic | 5 | 2023 | 1096 | 0.490 |
Why?
|
Male | 129 | 2024 | 360358 | 0.450 |
Why?
|
Arteriosclerosis | 1 | 2018 | 1056 | 0.450 |
Why?
|
Female | 130 | 2024 | 392148 | 0.440 |
Why?
|
Myocardial Revascularization | 6 | 2020 | 790 | 0.440 |
Why?
|
Rupture, Spontaneous | 6 | 2024 | 362 | 0.380 |
Why?
|
Neoplasms | 4 | 2023 | 22131 | 0.380 |
Why?
|
Angiocardiography | 1 | 2010 | 149 | 0.360 |
Why?
|
Cardiovascular System | 3 | 2023 | 834 | 0.350 |
Why?
|
Aged | 72 | 2024 | 169042 | 0.350 |
Why?
|
Reproducibility of Results | 23 | 2024 | 20074 | 0.320 |
Why?
|
Automation | 4 | 2017 | 585 | 0.320 |
Why?
|
Observer Variation | 9 | 2018 | 2606 | 0.320 |
Why?
|
Ultrasonography, Interventional | 7 | 2018 | 1496 | 0.320 |
Why?
|
Echocardiography, Stress | 3 | 2021 | 134 | 0.310 |
Why?
|
Myocardial Ischemia | 2 | 2018 | 2110 | 0.310 |
Why?
|
Sensitivity and Specificity | 27 | 2021 | 14648 | 0.300 |
Why?
|
Contrast Media | 15 | 2019 | 5305 | 0.300 |
Why?
|
Prospective Studies | 38 | 2024 | 54360 | 0.300 |
Why?
|
Heart Transplantation | 4 | 2013 | 3232 | 0.300 |
Why?
|
Periodicals as Topic | 4 | 2024 | 1463 | 0.290 |
Why?
|
Diffusion of Innovation | 5 | 2024 | 729 | 0.290 |
Why?
|
Diagnostic Imaging | 4 | 2023 | 3527 | 0.280 |
Why?
|
Leg | 2 | 2023 | 1087 | 0.280 |
Why?
|
Iohexol | 2 | 2019 | 204 | 0.280 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2020 | 575 | 0.280 |
Why?
|
Heart Function Tests | 3 | 2020 | 318 | 0.270 |
Why?
|
Enterococcus faecium | 3 | 2005 | 101 | 0.270 |
Why?
|
Heart Ventricles | 6 | 2020 | 3796 | 0.270 |
Why?
|
Adipose Tissue | 7 | 2024 | 3309 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 11 | 2017 | 8998 | 0.250 |
Why?
|
Cell Adhesion Molecules | 3 | 2001 | 1602 | 0.250 |
Why?
|
Triage | 6 | 2016 | 983 | 0.240 |
Why?
|
Peripheral Arterial Disease | 3 | 2022 | 1271 | 0.240 |
Why?
|
Arterial Occlusive Diseases | 2 | 2023 | 748 | 0.230 |
Why?
|
Evidence-Based Medicine | 7 | 2024 | 3680 | 0.230 |
Why?
|
Pericardium | 3 | 2020 | 664 | 0.220 |
Why?
|
Probiotics | 3 | 2005 | 378 | 0.220 |
Why?
|
Pulmonary Veins | 2 | 2024 | 716 | 0.220 |
Why?
|
Algorithms | 11 | 2020 | 14018 | 0.220 |
Why?
|
United States | 21 | 2024 | 72272 | 0.220 |
Why?
|
Superoxides | 4 | 2001 | 387 | 0.210 |
Why?
|
Acute Disease | 9 | 2019 | 7237 | 0.210 |
Why?
|
Aortic Valve | 5 | 2023 | 1955 | 0.210 |
Why?
|
Area Under Curve | 4 | 2015 | 1635 | 0.210 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2019 | 137 | 0.200 |
Why?
|
Coronary Circulation | 4 | 2024 | 1569 | 0.190 |
Why?
|
Consensus | 4 | 2024 | 3117 | 0.190 |
Why?
|
Telecommunications | 1 | 2021 | 79 | 0.190 |
Why?
|
Electrocardiography | 9 | 2017 | 6346 | 0.190 |
Why?
|
Inflammation | 8 | 2024 | 10760 | 0.190 |
Why?
|
Retrospective Studies | 25 | 2024 | 80566 | 0.180 |
Why?
|
Heart | 5 | 2024 | 4403 | 0.180 |
Why?
|
Journal Impact Factor | 1 | 2022 | 153 | 0.180 |
Why?
|
Phantoms, Imaging | 2 | 2006 | 2518 | 0.180 |
Why?
|
Cardiac Volume | 1 | 2021 | 196 | 0.170 |
Why?
|
Adult | 44 | 2024 | 220969 | 0.170 |
Why?
|
Curriculum | 2 | 2024 | 3738 | 0.170 |
Why?
|
Ventricular Function, Left | 3 | 2007 | 3873 | 0.170 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 479 | 0.170 |
Why?
|
Microvascular Angina | 1 | 2019 | 14 | 0.170 |
Why?
|
Venous Insufficiency | 1 | 2001 | 108 | 0.170 |
Why?
|
American Heart Association | 2 | 2022 | 1039 | 0.160 |
Why?
|
Multivariate Analysis | 7 | 2017 | 12043 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 10199 | 0.160 |
Why?
|
Biomedical Research | 3 | 2021 | 3426 | 0.160 |
Why?
|
Aorta | 2 | 2005 | 2041 | 0.160 |
Why?
|
ROC Curve | 6 | 2019 | 3575 | 0.160 |
Why?
|
Echocardiography | 6 | 2019 | 4987 | 0.150 |
Why?
|
Advisory Committees | 1 | 2022 | 787 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1565 | 0.150 |
Why?
|
Cohort Studies | 14 | 2023 | 41457 | 0.150 |
Why?
|
Preventive Health Services | 1 | 2022 | 566 | 0.140 |
Why?
|
Arteries | 1 | 2022 | 1122 | 0.140 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 239 | 0.140 |
Why?
|
Critical Pathways | 1 | 2021 | 474 | 0.140 |
Why?
|
Cardiotoxins | 1 | 2016 | 36 | 0.140 |
Why?
|
Adjuvants, Immunologic | 2 | 2000 | 990 | 0.140 |
Why?
|
Retroperitoneal Fibrosis | 1 | 2016 | 42 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2764 | 0.130 |
Why?
|
Odds Ratio | 7 | 2021 | 9643 | 0.130 |
Why?
|
Triiodobenzoic Acids | 5 | 2008 | 123 | 0.130 |
Why?
|
Phenotype | 4 | 2024 | 16571 | 0.130 |
Why?
|
Neutrophils | 6 | 2001 | 3763 | 0.130 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1927 | 0.120 |
Why?
|
Hospitalization | 8 | 2021 | 10704 | 0.120 |
Why?
|
Angina, Unstable | 4 | 2021 | 888 | 0.120 |
Why?
|
Inflammation Mediators | 2 | 2001 | 1884 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2021 | 735 | 0.120 |
Why?
|
Vasculitis | 1 | 2019 | 522 | 0.120 |
Why?
|
North America | 4 | 2019 | 1273 | 0.120 |
Why?
|
Aortic Valve Stenosis | 2 | 2023 | 2003 | 0.120 |
Why?
|
Disease Progression | 8 | 2017 | 13495 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 2 | 2008 | 307 | 0.120 |
Why?
|
Photography | 1 | 2017 | 532 | 0.120 |
Why?
|
Heart Valve Diseases | 2 | 2016 | 1028 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2023 | 1228 | 0.110 |
Why?
|
Ultrasonography | 5 | 2015 | 5964 | 0.110 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2015 | 1068 | 0.110 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1700 | 0.110 |
Why?
|
Time Factors | 12 | 2024 | 39913 | 0.110 |
Why?
|
Arteriovenous Fistula | 2 | 2024 | 319 | 0.100 |
Why?
|
Feasibility Studies | 4 | 2019 | 5239 | 0.100 |
Why?
|
Emergency Medical Services | 2 | 2018 | 1921 | 0.100 |
Why?
|
Aortitis | 1 | 2013 | 74 | 0.100 |
Why?
|
Mammaplasty | 1 | 2022 | 1232 | 0.100 |
Why?
|
Prevalence | 6 | 2019 | 15689 | 0.100 |
Why?
|
Software | 2 | 2017 | 4431 | 0.100 |
Why?
|
Radiotherapy | 1 | 2019 | 1497 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2022 | 3206 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2270 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6474 | 0.100 |
Why?
|
Health Records, Personal | 1 | 2013 | 127 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1779 | 0.090 |
Why?
|
Aortic Valve Insufficiency | 2 | 2007 | 576 | 0.090 |
Why?
|
Registries | 2 | 2018 | 8207 | 0.090 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 940 | 0.090 |
Why?
|
Reactive Oxygen Species | 1 | 1999 | 2137 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1265 | 0.090 |
Why?
|
Logistic Models | 5 | 2017 | 13245 | 0.090 |
Why?
|
Outpatients | 1 | 2018 | 1596 | 0.080 |
Why?
|
Quaternary Ammonium Compounds | 1 | 1990 | 202 | 0.080 |
Why?
|
Carotid Stenosis | 1 | 2017 | 859 | 0.080 |
Why?
|
Dyspnea | 1 | 2017 | 1347 | 0.080 |
Why?
|
Artifacts | 3 | 2007 | 1910 | 0.080 |
Why?
|
Women's Health | 1 | 2018 | 2065 | 0.080 |
Why?
|
Health Care Costs | 2 | 2019 | 3238 | 0.080 |
Why?
|
Aorta, Thoracic | 2 | 2013 | 1096 | 0.080 |
Why?
|
Diagnosis, Differential | 7 | 2019 | 12966 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2595 | 0.080 |
Why?
|
Lipid Metabolism | 2 | 2013 | 1896 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11736 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12447 | 0.070 |
Why?
|
Image Enhancement | 2 | 2017 | 2881 | 0.070 |
Why?
|
Troponin T | 1 | 2013 | 780 | 0.070 |
Why?
|
Collateral Circulation | 1 | 2008 | 293 | 0.070 |
Why?
|
Comprehension | 1 | 2013 | 620 | 0.070 |
Why?
|
Angiography | 2 | 2023 | 1596 | 0.070 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2008 | 148 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6807 | 0.070 |
Why?
|
Alzheimer Disease | 3 | 2006 | 8601 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 8 | 2023 | 36402 | 0.070 |
Why?
|
Myocardial Reperfusion | 1 | 2008 | 338 | 0.070 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2007 | 141 | 0.070 |
Why?
|
Markov Chains | 2 | 2020 | 965 | 0.070 |
Why?
|
Documentation | 1 | 2013 | 895 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1669 | 0.070 |
Why?
|
Sex Factors | 5 | 2021 | 10548 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2013 | 2650 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4058 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2372 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2012 | 4804 | 0.060 |
Why?
|
Atrial Fibrillation | 3 | 2011 | 5031 | 0.060 |
Why?
|
Catheter Ablation | 2 | 2011 | 2634 | 0.060 |
Why?
|
Chi-Square Distribution | 4 | 2013 | 3410 | 0.060 |
Why?
|
Lower Extremity | 2 | 2023 | 1200 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2023 | 39063 | 0.060 |
Why?
|
Cholesterol | 2 | 2023 | 2903 | 0.060 |
Why?
|
Integrin alpha4 | 1 | 2005 | 87 | 0.060 |
Why?
|
Electric Countershock | 1 | 2008 | 532 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2008 | 0.060 |
Why?
|
Incidence | 4 | 2017 | 21337 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8833 | 0.060 |
Why?
|
Aged, 80 and over | 11 | 2019 | 58894 | 0.060 |
Why?
|
Heart Atria | 2 | 2011 | 1333 | 0.060 |
Why?
|
Patient Discharge | 3 | 2024 | 3442 | 0.060 |
Why?
|
Immunotherapy | 1 | 2000 | 4642 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3356 | 0.060 |
Why?
|
Aspirin | 1 | 2015 | 3127 | 0.060 |
Why?
|
Glucuronidase | 3 | 2001 | 202 | 0.050 |
Why?
|
Single-Blind Method | 4 | 2009 | 1575 | 0.050 |
Why?
|
Fibrosis | 2 | 2024 | 2045 | 0.050 |
Why?
|
Nonlinear Dynamics | 1 | 2006 | 491 | 0.050 |
Why?
|
Angioplasty, Balloon | 1 | 2007 | 589 | 0.050 |
Why?
|
Echocardiography, Doppler | 1 | 2007 | 893 | 0.050 |
Why?
|
Muramidase | 2 | 2001 | 167 | 0.050 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 708 | 0.050 |
Why?
|
Neurofibrillary Tangles | 2 | 2006 | 457 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4803 | 0.050 |
Why?
|
Epigastric Arteries | 1 | 2022 | 92 | 0.050 |
Why?
|
Heart Rate | 4 | 2007 | 4180 | 0.050 |
Why?
|
Overweight | 1 | 2013 | 2417 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2006 | 829 | 0.050 |
Why?
|
Motion | 1 | 2006 | 779 | 0.050 |
Why?
|
Peroxidase | 3 | 2001 | 610 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2006 | 1066 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2003 | 527 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2005 | 2849 | 0.050 |
Why?
|
Adiposity | 2 | 2023 | 1879 | 0.050 |
Why?
|
Natural Language Processing | 2 | 2020 | 1163 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8645 | 0.050 |
Why?
|
Arteriovenous Malformations | 1 | 2024 | 396 | 0.050 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2005 | 1128 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3822 | 0.050 |
Why?
|
Calibration | 1 | 2003 | 817 | 0.050 |
Why?
|
Double-Blind Method | 5 | 2013 | 12334 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2001 | 127 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2016 | 6483 | 0.040 |
Why?
|
California | 2 | 2019 | 1430 | 0.040 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2023 | 269 | 0.040 |
Why?
|
Postoperative Care | 1 | 2007 | 1467 | 0.040 |
Why?
|
Societies, Scientific | 1 | 2021 | 222 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2018 | 5146 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2022 | 304 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9712 | 0.040 |
Why?
|
Syndrome | 4 | 2007 | 3268 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2008 | 2118 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2013 | 3599 | 0.040 |
Why?
|
Esophagus | 1 | 2005 | 1031 | 0.040 |
Why?
|
Lysosomes | 3 | 1994 | 924 | 0.040 |
Why?
|
Pyrazoles | 2 | 2019 | 2008 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5491 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7995 | 0.040 |
Why?
|
Linear Models | 2 | 2013 | 5866 | 0.040 |
Why?
|
Oregon | 1 | 2019 | 147 | 0.040 |
Why?
|
Boston | 4 | 2013 | 9313 | 0.040 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2001 | 361 | 0.040 |
Why?
|
Lipids | 2 | 2024 | 3332 | 0.040 |
Why?
|
Free Radicals | 1 | 1999 | 238 | 0.040 |
Why?
|
Decision Making | 2 | 2015 | 3918 | 0.040 |
Why?
|
Lactones | 1 | 2001 | 316 | 0.040 |
Why?
|
Animals | 9 | 2019 | 168201 | 0.040 |
Why?
|
Aortography | 2 | 2013 | 421 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 675 | 0.040 |
Why?
|
Sulfones | 1 | 2001 | 447 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 879 | 0.040 |
Why?
|
Chronic Disease | 2 | 2024 | 9311 | 0.040 |
Why?
|
Radiation Dosage | 2 | 2018 | 1956 | 0.040 |
Why?
|
Spain | 1 | 2019 | 487 | 0.040 |
Why?
|
Mortality | 2 | 2019 | 2899 | 0.040 |
Why?
|
Anticholesteremic Agents | 1 | 2005 | 967 | 0.040 |
Why?
|
Brachial Artery | 1 | 2019 | 366 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 1990 | 4174 | 0.040 |
Why?
|
Physical Examination | 1 | 2023 | 1254 | 0.040 |
Why?
|
Antibody Formation | 2 | 2000 | 1390 | 0.040 |
Why?
|
Protein Synthesis Inhibitors | 4 | 1962 | 189 | 0.030 |
Why?
|
Obesity | 2 | 2023 | 12933 | 0.030 |
Why?
|
Lymphocytes | 1 | 2005 | 2604 | 0.030 |
Why?
|
Reference Values | 1 | 2004 | 4919 | 0.030 |
Why?
|
Blood Bactericidal Activity | 1 | 1976 | 124 | 0.030 |
Why?
|
Purines | 1 | 2019 | 606 | 0.030 |
Why?
|
Antioxidants | 2 | 2006 | 1668 | 0.030 |
Why?
|
Cardiomyopathies | 1 | 2007 | 1948 | 0.030 |
Why?
|
Singapore | 1 | 2016 | 292 | 0.030 |
Why?
|
Monocytes | 1 | 2005 | 2565 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 20988 | 0.030 |
Why?
|
Tetracycline | 3 | 1961 | 216 | 0.030 |
Why?
|
Models, Economic | 1 | 2019 | 714 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2003 | 6224 | 0.030 |
Why?
|
Electrodes | 1 | 2017 | 610 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2379 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1884 | 0.030 |
Why?
|
Phagocytosis | 2 | 2000 | 1526 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2006 | 3113 | 0.030 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 1994 | 125 | 0.030 |
Why?
|
Mastectomy | 1 | 2022 | 1817 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1550 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 912 | 0.030 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2013 | 119 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13635 | 0.030 |
Why?
|
Practice Guidelines as Topic | 4 | 2014 | 7389 | 0.030 |
Why?
|
Iopamidol | 1 | 2013 | 186 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4237 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1040 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1517 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 802 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1722 | 0.030 |
Why?
|
Cell Communication | 1 | 2000 | 1654 | 0.030 |
Why?
|
Minority Groups | 1 | 2019 | 1202 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1454 | 0.030 |
Why?
|
Blood Pressure | 1 | 2008 | 8472 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2188 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1610 | 0.020 |
Why?
|
Catalase | 3 | 1976 | 218 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 1994 | 693 | 0.020 |
Why?
|
Sulfonamides | 1 | 2001 | 1977 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 739 | 0.020 |
Why?
|
Intestines | 1 | 2000 | 1909 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 831 | 0.020 |
Why?
|
Age Distribution | 2 | 2008 | 2871 | 0.020 |
Why?
|
Myocardial Contraction | 2 | 2006 | 1515 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2001 | 3705 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6961 | 0.020 |
Why?
|
Body Mass Index | 2 | 2024 | 12943 | 0.020 |
Why?
|
Reference Standards | 1 | 2013 | 1002 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1431 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1998 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4117 | 0.020 |
Why?
|
Chelating Agents | 2 | 1961 | 387 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3567 | 0.020 |
Why?
|
Granulocytes | 1 | 1990 | 551 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5061 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2008 | 174 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3877 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 22148 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1293 | 0.020 |
Why?
|
Risk | 2 | 2012 | 9604 | 0.020 |
Why?
|
Brain | 2 | 2006 | 27101 | 0.020 |
Why?
|
Electrophoresis, Paper | 1 | 1965 | 14 | 0.020 |
Why?
|
Proteus | 1 | 1965 | 11 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8426 | 0.020 |
Why?
|
Achromobacter | 1 | 1965 | 8 | 0.020 |
Why?
|
Cytokines | 1 | 2001 | 7373 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18381 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5835 | 0.020 |
Why?
|
Ornithine | 1 | 1965 | 79 | 0.020 |
Why?
|
Cause of Death | 1 | 2016 | 3683 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6305 | 0.020 |
Why?
|
Electrophoresis | 1 | 1965 | 226 | 0.020 |
Why?
|
Cathepsins | 2 | 1977 | 241 | 0.020 |
Why?
|
Carboxy-Lyases | 1 | 1965 | 85 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 26049 | 0.020 |
Why?
|
Pseudomonas | 1 | 1965 | 124 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2018 | 64568 | 0.020 |
Why?
|
Chickens | 3 | 1977 | 858 | 0.010 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 823 | 0.010 |
Why?
|
Histidine | 1 | 1965 | 308 | 0.010 |
Why?
|
Glutamates | 1 | 1965 | 389 | 0.010 |
Why?
|
Enterobacteriaceae | 1 | 1965 | 161 | 0.010 |
Why?
|
Phenylalanine | 1 | 1965 | 365 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4321 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10505 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2745 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2004 | 573 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10754 | 0.010 |
Why?
|
Tissue Donors | 1 | 2013 | 2331 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2925 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3797 | 0.010 |
Why?
|
Myocardium | 2 | 2008 | 4724 | 0.010 |
Why?
|
Tryptophan | 1 | 1965 | 482 | 0.010 |
Why?
|
Stroke Volume | 2 | 2007 | 5486 | 0.010 |
Why?
|
Aspartic Acid | 1 | 1965 | 576 | 0.010 |
Why?
|
Physicians | 1 | 2021 | 4583 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 6174 | 0.010 |
Why?
|
Heart Failure | 1 | 2006 | 11669 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2004 | 957 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12719 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1963 | 411 | 0.010 |
Why?
|
Arginine | 1 | 1965 | 933 | 0.010 |
Why?
|
Plaque, Amyloid | 1 | 2006 | 760 | 0.010 |
Why?
|
Ciguatera Poisoning | 1 | 1961 | 1 | 0.010 |
Why?
|
Fish Venoms | 1 | 1961 | 3 | 0.010 |
Why?
|
Serine | 1 | 1965 | 830 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1963 | 414 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2006 | 747 | 0.010 |
Why?
|
Brucella | 1 | 1961 | 10 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 1963 | 247 | 0.010 |
Why?
|
Microspheres | 1 | 2004 | 782 | 0.010 |
Why?
|
Foodborne Diseases | 1 | 1961 | 41 | 0.010 |
Why?
|
Tyrosine | 1 | 1965 | 1440 | 0.010 |
Why?
|
Oxidoreductases | 1 | 1963 | 412 | 0.010 |
Why?
|
Lysine | 1 | 1965 | 993 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7960 | 0.010 |
Why?
|
Oxyquinoline | 1 | 1960 | 16 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1253 | 0.010 |
Why?
|
Tetracyclines | 1 | 1960 | 64 | 0.010 |
Why?
|
Citrates | 1 | 1960 | 133 | 0.010 |
Why?
|
Citric Acid | 1 | 1960 | 123 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11069 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1972 | 0.010 |
Why?
|
Amino Acids | 1 | 1965 | 1717 | 0.010 |
Why?
|
Histamine | 1 | 1961 | 499 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5073 | 0.010 |
Why?
|
Anti-Bacterial Agents | 4 | 1962 | 7402 | 0.010 |
Why?
|
Astrocytes | 1 | 2006 | 1341 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13347 | 0.010 |
Why?
|
Fishes | 1 | 1961 | 602 | 0.010 |
Why?
|
Triglycerides | 1 | 2005 | 2459 | 0.010 |
Why?
|
Microglia | 1 | 2006 | 1357 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14591 | 0.010 |
Why?
|
Administration, Oral | 1 | 2005 | 4010 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29868 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 2004 | 1411 | 0.010 |
Why?
|
Pepstatins | 1 | 1976 | 10 | 0.010 |
Why?
|
Acid Phosphatase | 1 | 1976 | 139 | 0.010 |
Why?
|
Mitral Valve | 1 | 2004 | 1464 | 0.010 |
Why?
|
Survival Analysis | 1 | 2008 | 10073 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1976 | 531 | 0.010 |
Why?
|
DDT | 1 | 1974 | 32 | 0.010 |
Why?
|
Thymidine | 1 | 1994 | 297 | 0.010 |
Why?
|
Respiratory Burst | 1 | 1994 | 110 | 0.010 |
Why?
|
Bacteria | 1 | 1965 | 2192 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59179 | 0.010 |
Why?
|
Swine | 1 | 2004 | 5907 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1994 | 817 | 0.010 |
Why?
|
Escherichia coli | 1 | 1965 | 4209 | 0.010 |
Why?
|
Rabbits | 2 | 1977 | 4770 | 0.010 |
Why?
|
Length of Stay | 1 | 2006 | 6418 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88234 | 0.010 |
Why?
|
Immunity | 1 | 1977 | 994 | 0.010 |
Why?
|
Antigens | 1 | 1974 | 1441 | 0.000 |
Why?
|
Cell Division | 1 | 1994 | 4457 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6126 | 0.000 |
Why?
|
Chlortetracycline | 1 | 1962 | 5 | 0.000 |
Why?
|
Oxytetracycline | 1 | 1962 | 11 | 0.000 |
Why?
|
Staphylococcus | 1 | 1962 | 153 | 0.000 |
Why?
|
Virulence | 1 | 1963 | 1299 | 0.000 |
Why?
|
Complement Fixation Tests | 1 | 1977 | 68 | 0.000 |
Why?
|
Hemagglutination Tests | 1 | 1977 | 76 | 0.000 |
Why?
|
Hemagglutination | 1 | 1974 | 32 | 0.000 |
Why?
|
Immunoglobulin G | 2 | 1977 | 4533 | 0.000 |
Why?
|
Sheep | 1 | 1974 | 1436 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1974 | 1526 | 0.000 |
Why?
|
Macrophages | 1 | 1977 | 5758 | 0.000 |
Why?
|